Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xin-Yi Lan"'
Autor:
Li-ying Jia, Gui-yun Cao, Jia Li, Lu Gan, Jin-xin Li, Xin-yi Lan, Zhao-qing Meng, Xin He, Chun-feng Zhang, Chong-Zhi Wang, Chun-Su Yuan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a commercially available Chinese patent medicine that has been widely used as the treatment of coronary heart disease (CHD). Its mechanisms against coronary heart dise
Externí odkaz:
https://doaj.org/article/591aeb8a341a4d79b1d3d948f5a00afb
Publikováno v:
Transactions of Nonferrous Metals Society of China. 33:1258-1270
Autor:
Fei Li, Chun-Su Yuan, Hui Yu, Chun-Feng Zhang, Shuo Zhai, Xin-Yi Lan, Chong-Zhi Wang, Qiu-Jing Chen
Publikováno v:
Phytotherapy Research. 34:2665-2674
Purpose The aim of the study was to investigate the effect of liquiritin on neuroendocrine-immune network in menopausal rat model. Methods Liquiritin groups were respectively given liquiritin suspension at the dose of 80, 40, and 20 mg/kg, once a day
Autor:
Jin-xin Li, Xin-Yi Lan, Chun-Feng Zhang, Lu Gan, Xiao-Fan Zhang, Gui-yun Cao, Chao-lin Yang, Jia Li, Zhao-qing Meng
Publikováno v:
The American Journal of Chinese Medicine. 48:107-126
The Chinese patent medicine She-Xiang-Xin-Tong-Ning (SXXTN) is a clinical medication for coronary heart disease (CHD) and angina pectoris. This study aimed to investigate pharmacological effects of SXXTN and elucidate the role in angiogenesis on huma
Autor:
Zhao-qing Meng, Gui-yun Cao, Jin-xin Li, Chun-Su Yuan, Xin-Yi Lan, Chun-Feng Zhang, Li-ying Jia, Lu Gan, Chong-Zhi Wang, Jia Li, Xin He
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a commercially available Chinese patent medicine that has been widely used as the treatment of coronary heart disease (CHD). Its mechanisms against coronary heart dise
Autor:
Li-ying Jia, Xin-Yi Lan, Chao-lin Yang, Jia Li, Jin-xin Li, Gui-yun Cao, Chun-Feng Zhang, Lu Gan, Zhao-qing Meng
Background SheXiang XinTongNing, a commercially available Chinese patent medicine, has been widely used in the treatment of coronary heart disease. However, the mechanisms of SheXiang XinTongNing are still unclear. The aim of this study was to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896f057d767a1bcac7f825014a7b5403
https://doi.org/10.21203/rs.3.rs-21814/v1
https://doi.org/10.21203/rs.3.rs-21814/v1
Autor:
Jia, Li, Gui-Yun, Cao, Xiao-Fan, Zhang, Zhao-Qing, Meng, Lu, Gan, Jin-Xin, Li, Xin-Yi, Lan, Chao-Lin, Yang, Chun-Feng, Zhang
Publikováno v:
The American journal of Chinese medicine. 48(1)
The Chinese patent medicine
Autor:
Chong-Zhi Wang, Chun-Su Yuan, Lu Gan, Cheng-Long Cui, Jia Li, Chun-Feng Zhang, Xin-Yi Lan, Fei Li
Publikováno v:
Polymer Composites. 40:2187-2196
Publikováno v:
Journal of Natural Medicines. 72:675-685
Rheumatoid arthritis (RA) is one of the most prevalent chronic inflammatory and angiogenic diseases. The aim of this study was to evaluate the anti-inflammatory and anti-angiogenic activities in vitro of eight diterpenoids isolated from Daphne genkwa
Autor:
Chun-Su Yuan, Wei Xiao, Chun-Feng Zhang, Wen-Zhe Huang, Wen-Juan Du, Jia Li, Jun Ji, Zhen-Zhong Wang, Xin He, Ling Wang, Chong-Zhi Wang, Jun-Qiu Lei, Xin-Yi Lan
Publikováno v:
Biomedical chromatography : BMC. 31(12)
Daphne genkwa Sieb.et Zucc. is a well-known medicinal plant. This study was designed to apply the ultra-high performance liquid chromatography (UPLC) system to establish a quality control method of Daphne genkwa. Data revealed that there were fifteen